JAKi rips STAT3 in cancer

Nature Medicine

Volumn 16, Issue 10, 2010, Pages 1085-1087

  Greten, Florian R ^a   Karin, Michael ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZD 1480; AZD 960; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 1; JANUS KINASE 2; JANUS KINASE 2 INHIBITOR; JANUS KINASE 3; STAT3 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CANCER SURVIVAL; CYTOKINE PRODUCTION; GENETIC TRANSCRIPTION; MYELOPROLIFERATIVE DISORDER; NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SHORT SURVEY; ANIMAL; ARTICLE; DRUG ANTAGONISM; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; JANUS KINASE 2; NEOPLASMS; NF-KAPPA B; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 77957783913     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1010-1085     Document Type: Short Survey

References (13)

1. Hedvat, M. et al. Cancer Cell 16, 487-497 (2009).
2. Yu, H., Pardoll, D. & Jove, R. Nat. Rev. Cancer 9, 798-809 (2009).
3. Bollrath, J. & Greten, F.R. EMBO Rep. 10, 1314-1319 (2009).
4. Grivennikov, S.I., Greten, F.R. & Karin, M. Cell 140, 883-899 (2010).
5. Pardanani, A. Leukemia 22, 23-30 (2008).
6. Yu, H., Kortylewski, M. & Pardoll, D. Nat. Rev. Immunol. 7, 41-51 (2007).
7. Grivennikov, S. & Karin, M. Cancer Cell 13, 7-9 (2008).
8. O'Shea, J.J., Park, H., Pesu, M., Borie, D. & Changelian, P. Curr. Opin. Rheumatol. 17, 305-311 (2005).
9. Digicaylioglu, M. & Lipton, S.A. Nature 412, 641-647 (2001).
10. Karin, M. & Greten, F.R. Nat. Rev. Immunol. 5, 749-759 (2005).
11. Bollrath, J. et al. Cancer Cell 15, 91-102 (2009).
12. Parganas, E. et al. Cell 93, 385-395 (1998).
13. Neubauer, H. et al. Cell 93, 397-409 (1998).